84-2191-17　［取扱停止］FMO3 (Hepatic Flavin-containing Monooxygenase 3, TMAU, FMOII, dJ127D3.1) 50ul　210870

特徴

• Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous- containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds.
• The human FMO gene family is composed of 5 genes and multiple pseudogenes.
• FMO members have distinct developmental- and tissue-specific expression patterns.
• The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals.
• This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry.
• This transmembrane protein localizes to the endoplasmic reticulum of many tissues.
• Alternative splicing of this gene results in multiple transcript variants encoding the same protein.
• Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor.
• In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.
• Applications:Suitable for use in Western Blot.
• Other applications not tested.
• Recommended Dilution:Western Blot: 1:500-1:2000Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4°C for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20°C.
• Aliquots are stable for 12 months after receipt.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.